Binnopharm Group to acquire two anti-bacterial brands from Dr Reddy’s 

Through its affiliate Joint Stock Company, Alium, Binnopharm Group will acquire the two anti-bacterial brands Ciprolet and Levolet in Russia, Belarus and Uzbekistan to strengthen its antibiotic portfolio

Binnopharm Group and Dr Reddy’s Laboratories today announced the signing of a deal that will allow Binnopharm Group to acquire anti-bacterial medicines under the Ciprolet and Levolet brands from Dr Reddy’s in Russia, Uzbekistan and Belarus. The portfolio includes various dosage forms such as tablets, solution for infusions and eye drops, the two companies said in a joint statement.

During the transition period, Dr Reddy’s will continue to supply the product to Binnopharm Group to ensure availability in the market, the statement added.

Binnopharm GroupCiproletDr Reddy's LaboratoriesLevolet
Comments (0)
Add Comment